PTK2 and hepatocellular carcinoma: Furthermore, the stimulation of CypA/CD147 signaling induces radiotherapy resistance in hepatocellular carcinoma through the interaction with integrin β1 and activation of the downstream FAK/PI3K-Akt pathway.